» Articles » PMID: 26460048

Noninvasive Monitoring of Infection and Rejection After Lung Transplantation

Abstract

The survival rate following lung transplantation is among the lowest of all solid-organ transplants, and current diagnostic tests often fail to distinguish between infection and rejection, the two primary posttransplant clinical complications. We describe a diagnostic assay that simultaneously monitors for rejection and infection in lung transplant recipients by sequencing of cell-free DNA (cfDNA) in plasma. We determined that the levels of donor-derived cfDNA directly correlate with the results of invasive tests of rejection (area under the curve 0.9). We also analyzed the nonhuman cfDNA as a hypothesis-free approach to test for infections. Cytomegalovirus is most frequently assayed clinically, and the levels of CMV-derived sequences in cfDNA are consistent with clinical results. We furthermore show that hypothesis-free monitoring for pathogens using cfDNA reveals undiagnosed cases of infection, and that certain infectious pathogens such as human herpesvirus (HHV) 6, HHV-7, and adenovirus, which are not often tested clinically, occur with high frequency in this cohort.

Citing Articles

Donor-derived cell-free DNA for detection of acute rejection in lung transplant recipients.

Yavuz G, Walter J, Hirv K, Wachter O, Dick A, Kovacs J Front Immunol. 2025; 16:1531774.

PMID: 39944692 PMC: 11814210. DOI: 10.3389/fimmu.2025.1531774.


Integrating Donor Derived Cell-Free DNA Fraction and Absolute Quantification for Enhanced Rejection Diagnosis in Kidney Transplant Recipients.

Nie W, Wang Y, Fu Q, Wu C, Deng R, Yu X Diagnostics (Basel). 2025; 15(3).

PMID: 39941167 PMC: 11817499. DOI: 10.3390/diagnostics15030237.


Donor-derived cell-free DNA in chronic lung allograft dysfunction phenotypes: a pilot study.

Beeckmans H, Pagliazzi A, Kerckhof P, Hofkens R, Debackere F, Zajacova A Front Transplant. 2025; 3:1513101.

PMID: 39764156 PMC: 11701071. DOI: 10.3389/frtra.2024.1513101.


Gene expression profiling in PBMCs for acute rejection in lung transplant recipients reveals myeloid responses.

Liu S, Westra J, Hu S, Verschuuren E, van Kempen L, van Baarle D Front Transplant. 2025; 3:1508419.

PMID: 39744543 PMC: 11688322. DOI: 10.3389/frtra.2024.1508419.


Donor derived cell free DNA in lung transplant recipients rises in setting of allograft instability.

Smith J, Peterson R, Pomponio R, Steele M, Gray A Front Transplant. 2024; 3:1497374.

PMID: 39737412 PMC: 11683734. DOI: 10.3389/frtra.2024.1497374.


References
1.
Dascomb K, Frazer T, Clark R, Kissinger P, Didier E . Microsporidiosis and HIV. J Acquir Immune Defic Syndr. 2000; 24(3):290-2. DOI: 10.1097/00126334-200007010-00018. View

2.
Langmead B, Salzberg S . Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012; 9(4):357-9. PMC: 3322381. DOI: 10.1038/nmeth.1923. View

3.
Touinssi M, Gallian P, Biagini P, Attoui H, Vialettes B, Berland Y . TT virus infection: prevalence of elevated viraemia and arguments for the immune control of viral load. J Clin Virol. 2001; 21(2):135-41. DOI: 10.1016/s1386-6532(01)00157-3. View

4.
Larroche C, Agbalika F, Poirel H, Martin A, Gautheret-Dejean A, Raphael M . Epstein-Barr virus and human herpesvirus 8 coinfection and concomitant extranodal nasal-type NK/T cell lymphoma and Castleman disease: case report. Clin Infect Dis. 2003; 36(9):e107-10. DOI: 10.1086/374663. View

5.
Zamora M . Cytomegalovirus and lung transplantation. Am J Transplant. 2004; 4(8):1219-26. DOI: 10.1111/j.1600-6143.2004.00505.x. View